Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients

The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Critical Ill Patients

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

About this study

Primary (Main): determine the levels of the GHI And RDW In Critically Ill Patients at Critical and intermediate care units.

b. Secondary (Subsidiary): Evaluate the prognostic significance of these parameters on patient outcomes, such as overall survival, progression-free survival, response to treatment.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients admitted to Critical and Intermediate Care Units in Internal Medicine Department after history taking, examination and diagnosis
diabtic Patients 3-animic Patients

Exclusion criteria

Patients under 18 years of age
ICU stay < 24 h
patients without HbA1c, FBG, or RDW data or anything's that's affect the HbA1c .

Treatment and study plan

Hbg and RDW

Device

Hbg and RDW as prognstic indicator in critical ill patients

Primary outcomes

Glycated Hemoglobin level

Time frame: Baseline

Measurement of Hb level in all patients upon ICU admission.
Red Cell Distribution Width (RDW)

Time frame: baseline

Measurement of RDW in all patients upon ICU admission.
Hemoglobin (Hb) Level

Time frame: baseline

Measurement of Hb level in all patients upon ICU admission.

Study contacts

Contact information is provided by the study sponsor or research team.

Alaa ELdean Abd Elmoniem, Prof

CONTACT

[email protected]

+201112732730

Rania Moukhter Aziz eldeam

CONTACT

[email protected]

+201022004702

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Glycatetd Hemoglobin Index and Red Cell Distribution Width as Prognstic Indicator in Critical Ill Patients

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Jul 9, 2025
Registry last updated: Jul 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting